THE TRUTH ABOUT: Reshape lifesciences | History Defined

Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 44 companies hit new 52-week lows.

Benzinga · Oct 4, 2022

Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 37 stocks hit new 52-week lows.

Benzinga · Aug 16, 2022

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

Bristol Myers Squibb (NYSE:BMY) and 2seventy bio (NASDAQ:TSVT) announced positive topline results from KarMMa-3, a Phase 3 study evaluating Abecma (idecabtagene vicleucel) compared to standard combination regimens in adults with multiple myeloma that is relapsed and refractory. Bristol Myers shares traded in a range of $73.95 to $75.32 on a day volume…

Benzinga · Aug 10, 2022

Stocks That Hit 52-Week Lows On Wednesday

  During Wednesday's trading, 435 companies set new 52-week lows.

Benzinga · May 4, 2022

Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

Benzinga · Apr 28, 2022

Earnings Preview For Reshape Lifesciences

Reshape Lifesciences (NASDAQ:RSLS) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Reshape Lifesciences will report an earnings per share (EPS) of $-0.17.

Benzinga · Mar 25, 2022